Skip to main content
. 2019 Mar 5;93(6):e01404-18. doi: 10.1128/JVI.01404-18

TABLE 3.

NTPDase inhibitor compounds tested in PhaHV1 NTPDase inhibition studies

Inhibitor no. Inhibitor Formula Mol wt (Da)
1 PV1 Na6(H2W12O40)·21H2O 3,366
2 PV2 H3(PW12O40)·H2O 2,880
3 PV3 K7(Ti2W10PO40)·8H2O 3,023
4 PV4 K6H2(TiW11CoO40)·13H2O 3,240
5 PV5 K10[Co4(H2O)2(PW9O34)2]·22H2O 5,518
6 PV6 (NH4)18(NaSb9W21O86)·14H2O 6,932
7 NaPW12 Na3(PW12O40)·7H2O 3,074
8 NaP6W18 Na20(P6W18O79)·37H2O 5,888
9 NaP5W30 Na1(NaP5W30O110)·30H2O 8,320
10 Reactive blue 2 C29H20ClN7Na3O11S3 774
11 KB1 K4[(Re6S8)(OH)6]·8H2O 1,776
12 KB2 K4[(Re6Se8)(OH)6]·8H2O 2,151
13 KB3 K4[(Re6S8)(CH3COO)6]·8H2O 2,028
14 KB4 K4[(Re6S8)(HCOO)6]·3H2O 1,854
15 Le135 C29H30N2O2 439
16 Resveratrol C14H12O3 228
17 Quercetin C15H10O7 302
18 Suramin C51H40N6O23S6 1,297
19 Methotrexate C20H22N8O5 454
20 IBMXa C10H14N4O2 222
a

IBMX, 3-isobutyl-1-methylxanthine.